CGT centers
BIOOCUS Medical Group is a global platform dedicated to advancing cellular and gene therapies, empowering patients worldwide to access cutting-edge treatments at relatively affordable prices. Through our strategically located CGT (Cellular and Gene Therapy) centers and collaborative network, we bridge innovation with accessibility across borders.
Currently operating four state-of-the-art facilities within top-tier oncology and hematology hospitals in Beijing and Tianjin, China, BIOOCUS combines world-class clinical expertise with cost-efficient solutions. By integrating pioneering research, advanced manufacturing, and partnerships with prestigious institutions, we ensure groundbreaking therapies remain within financial reach for diverse patient needs.
Our CGT centers deliver transformative therapies including:
●CAR-T Therapy for blood cancers (leukemia, lymphoma)
●TILs Therapy targeting solid tumors (melanoma, others)
●NK Cell Therapy for cancers and immune disorders
●Gene Therapy for Sickle Cell Disease & β-Thalassemia
From hematologic conditions to complex malignancies, BIOOCUS redefines care through science-driven affordability. We collaborate globally to match patients with optimal therapies while maintaining transparent pricing models – because life-saving innovation should transcend economic barriers.
